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Representative hysteresis curves for parallel duplexes ( Fig. S7 ) S12 Scheme S1. Synthetic outline of phosphoramidites 5X and 5Y. CAN = ceric ammonium nitrate, DMTr = 4,4'-dimethoxytrityl, TBAF = tetrabutylammonium fluoride, PCl = 2-cyanoethyl N, N'-diisopropylchlorophosphoramidite.
Synthesis and purification of oligodeoxyribonucleotides:
The 0.2 umol scale synthesis of oligodeoxyribo-nucleotides (ONs) containing LNA (V), C5-ethynyl (X) or C5-propargylamine (Y) functionalized LNA monomers was performed on an Expedite 8909 Synthesizer using succinyl linked LCAA-CPG (long chain alkyl amine controlled pore glass) columns with a pore size of 500 Å.
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Standard protocols for incorporation of DNA phosphoramidites were used, while extended coupling times (15 min) and oxidations (45 sec) were used for incorporation of all LNA-type building blocks.
Cleavage from solid support, removal of protecting groups and conversion of O4-triazolyl-dT monomers to 5-methyl-dC monomers ( m C) was accomplished by treatment with 32% aq. ammonia (24-48 h, rt). All ONs were purified by RP-HPLC in DMT-on mode as described below. The DMT-10 group was subsequently cleaved using 80% aq. AcOH, followed by precipitation (acetone, -18 °C for 12-16 h).
Purification of the crude ONs was performed on a Varian Prostar HPLC system equipped with an XTerra MS C18 pre-column (10um, 7.8×10 mm) using the representative gradient protocol depicted in Table S1 . The composition of all synthesized ONs was verified by MALDI-MS/MS analysis ( Table   15 S2) recorded in positive mode on a Quadrupole Time-Of-Flight tandem Mass Spectrometer (Q-TOF Premiere) equipped with a MALDI source (Waters Micromass LTD., U. K.) using anthranilic acid as a matrix, while purity (>80%) was verified by RP-HPLC (Table S1 ). Table S1 . Representative RP-HPLC gradient protocol. Table 1 . Conditions: 1:1-ratio TFO:dsDNA (each ON at 1 μM), 5 pH 7.2 HEPES buffer (50 mM HEPES, 10 mM MgCl 2 , 150 mM NaCl, 10% sucrose and 1 mg/mL spermine tetra-HCl). Preparation: denaturation at 90 °C for 5 min followed by incubation at rt for 4h. Electrophoresis: 12% non-denaturing PAGE run at temperatures below rt. SYBR gold staining was used for visualization. HCl, 10 mM MgCl 2 , pH 9.0) at 37 °C, to which SVPDE dissolved in H 2 O was added (0.43 μg in 10 μL).
The absorbance at t = 0 min was normalized for all investigated TFOs, while the observed absorbance after exposing reference TFO T1 to the abovementioned conditions for 2.5 h was assumed to indicate full degradation. Table 2 . experiments (see Table 1 ). Interestingly, significant hysteresis was observed for parallel duplex involves denaturation of the triplex to three single strands as recently suggested in TFO-studies with LNA analogs (Fig. S7) Table S3 .
